Cargando…
Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
Rapid-response vaccine production platform technologies, including RNA vaccines, are being developed to combat viral epidemics and pandemics. A key enabler of rapid response is having quality-oriented disease-agnostic manufacturing protocols ready ahead of outbreaks. We are the first to apply the Qu...
Autores principales: | van de Berg, Damien, Kis, Zoltán, Behmer, Carl Fredrik, Samnuan, Karnyart, Blakney, Anna K., Kontoravdi, Cleo, Shattock, Robin, Shah, Nilay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085199/ https://www.ncbi.nlm.nih.gov/pubmed/33927197 http://dx.doi.org/10.1038/s41541-021-00322-7 |
Ejemplares similares
-
Rapid development and deployment of high‐volume vaccines for pandemic response
por: Kis, Zoltán, et al.
Publicado: (2020) -
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
por: Kis, Zoltán, et al.
Publicado: (2020) -
Correction: Kis, Z. et al. Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand. Vaccines 2021, 9, 3
por: Kis, Zoltán, et al.
Publicado: (2021) -
Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA
por: Blakney, Anna K., et al.
Publicado: (2021) -
Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK
por: Ibrahim, Dauda, et al.
Publicado: (2021)